Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils

Abstract

AbstractBackground and ObjectivesThe isolation of neutrophils and subsequent detection of anti‐human neutrophil antigens (HNA) antibodies are crucial in clinical medicine for the diagnosis of autoimmune neutropenia, neonatal alloimmune neutropenia (NAIN) and transfusion‐related acute lung injury (TRALI). This study reports two cases of maternal anti‐Fc‐gamma‐receptor‐IIIb (FcγRIIIb) isoimmunization without NAIN symptoms and compares the efficiency of immunomagnetic negative selection (IMNS) with traditional dextran/Ficoll for neutrophil isolation in HNA serological assays.Materials and MethodsInvestigating two cases of maternal anti‐FcγRIIIb isoimmunization, neutrophils from three donors were isolated from 8 mL of whole blood using IMNS and dextran/Ficoll. Serological assays included the granulocyte agglutination and immunofluorescence test, monoclonal antibody immobilization of granulocyte antigens and the LABScreen Multi (One Lambda). IMNS and dextran/Ficoll were compared in terms of cell yield, viability, time, cost and purity.ResultsMaternal anti‐FcγRIIIb isoantibodies with FCGR3B gene deletion were detected in both cases. Newborns and fathers exhibited specific gene combinations: FCGR3B*02/FCGR3B*02 (Case 1) and FCGR3B*02/FCGR3B*03 (Case 2). IMNS outperformed dextran/Ficoll, yielding four times more neutrophils (average neutrophil counts: 18.5 × 103/μL vs. 4.5 × 103/μL), efficiently removing non‐neutrophil cells and reducing processing time (30–40 min vs. 70–90 min), although it incurred a higher cost (2.7 times).ConclusionTwo cases of maternal anti‐FcγRIIIb isoantibodies, unrelated to NAIN, were identified. Although neutropenia has not been described in these cases, we emphasize the importance of identifying asymptomatic cases with the potential for severe neutropenia. Additionally, IMNS is introduced as a rapid, high‐yield, high‐purity neutrophil isolation technique, beneficial for serological assays detecting anti‐HNA antibodies.